• Journal of Innovative Optical Health Sciences
  • Vol. 8, Issue 1, 1530001 (2015)
Tinghui Li1、2、*, Hong Deng3, Jingquan Zhao3, and Ying Gu1
Author Affiliations
  • 1Department of Laser Medicine, Chinese PLA General Hospital, Beijing, People's Republic of China 100853
  • 2Department of Dermatology, 309 Hospital of PLA,
  • 3Beijing National Laboratory for Molecular Sciences (BNLMS), Key Laboratory of Photochemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing, People's Republic of China 100190
  • show less
    DOI: 10.1142/s1793545815300013 Cite this Article
    Tinghui Li, Hong Deng, Jingquan Zhao, Ying Gu. Elsinochrome A photosensitizers: Alternative drugs for photodynamic therapy[J]. Journal of Innovative Optical Health Sciences, 2015, 8(1): 1530001 Copy Citation Text show less

    Abstract

    Photodynamic therapy (PDT) has already been a multifunctional modality for various tumors and nontumorous diseases. However, the development of photosensitizers is relatively delayed, compared with the tremendous progress in laser technology. Elsinochrome A (EA), a perylenequinonoid pigment from China, has all the typical advantages of perylenequinones. Moreover, singlet oxygen quantum yield of EA is superior to other kinds of photosensitizers and EA could be artificially biosynthesized at present, which make it an alternative candidate for PDT. In this review, the photophysics, photochemistry, photobiology and chemical or biological syntheses of EA photosensitizers are briefly presented. Besides, the future prospects of EA photosensitizers are also proposed.
    Tinghui Li, Hong Deng, Jingquan Zhao, Ying Gu. Elsinochrome A photosensitizers: Alternative drugs for photodynamic therapy[J]. Journal of Innovative Optical Health Sciences, 2015, 8(1): 1530001
    Download Citation